Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer HR Kazmi, A Chandra, J Nigam, M Noushif, D Parmar, V Gupta Digestive surgery 30 (3), 233-239, 2013 | 33 | 2013 |
Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker? J Nigam, A Chandra, HR Kazmi, D Parmar, D Singh, V Gupta Tumor Biology 35, 9241-9246, 2014 | 28 | 2014 |
Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: a comparative study J Nigam, A Chandra, HR Kazmi, A Singh, V Gupta, D Parmar, ... Medical Oncology 31, 1-5, 2014 | 25 | 2014 |
Prognostic significance of survivin in resected gallbladder cancer J Nigam, A Chandra, HR Kazmi, D Parmar, D Singh, V Gupta Journal of Surgical Research 194 (1), 57-62, 2015 | 24 | 2015 |
Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease? HR Kazmi, A Chandra, K Baghel, A Singh, J Nigam, D Parmar, AA Mahdi, ... BioMed research international 2014 (1), 625695, 2014 | 16 | 2014 |
A let-7 microRNA binding site polymorphism in the KRAS 3′ UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population HR Kazmi, A Chandra, S Kumar, LK Satyam, A Gupta, J Nigam, ... Journal of cancer research and clinical oncology 142, 2577-2583, 2016 | 14 | 2016 |
Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: An immunohistochemical study N Fatima, AN Srivastava, J Nigam, N Tandon, R Ahmad, V Kumar Indian Journal of Pathology and Microbiology 62 (3), 384-390, 2019 | 12 | 2019 |
Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study. KV Fatima N, Srivastava AN, Nigam J, Raza ST, Rizvi S, Siddiqui Z Asian Pac J Cancer Prev 20 (6), 1895-1900, 2019 | 10* | 2019 |
Expression and clinicopathological significance of antiapoptotis protein survivin in gallbladder cancer V Gupta, MM Goel, A Chandra, P Gupta, S Kumar, J Nigam Indian Journal of Pathology and Microbiology 59 (2), 143-147, 2016 | 7 | 2016 |
Polymorphism and expression profile of cholecystokinin type A receptor in relation to gallstone disease susceptibility HR Kazmi, A Chandra, J Nigam, K Baghel, M Srivastava, SS Maurya, ... Biochemical genetics 54, 665-675, 2016 | 3 | 2016 |
Expression of antimicrobial peptides and cytokines in human omentum following abdominal surgery M Srivastava, A Chandra, R Rahul, J Nigam, P Rajan, D Parmar, ... Cureus 13 (8), 2021 | 2 | 2021 |
Antibacterial spectrum of human omentum and differential expression of beta defensins M Srivastava, A Chandra, J Agarwal, R Rahul, J Nigam, D Parmar, ... Indian Journal of Gastroenterology 38, 303-309, 2019 | 2 | 2019 |
Study of CCK1R and CCK2R heterodemerization in gallbladder cancer: a new mechanism for carcinogenesis R Jain, J Nigam, G Deeban, S Tripathi, M Arun, P Rajan, M Raj, A Bansal HPB 26, S819, 2024 | | 2024 |
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis J Nigam, HR Kazmi, L Khare, M Srivastava, A Chandra Journal of Cancer Research and Clinical Oncology 149 (10), 7069-7078, 2023 | | 2023 |
Prognostic Significance of Inhibitor of Apoptosis Proteins in Gallbladder Cancer A Chandra, J Nigam, P Rajan, V Gupta, M Rajashekhara, R Patel, ... Journal of the American College of Surgeons 233 (5), e113, 2021 | | 2021 |
Expression and heterodimerization of Type A and B Cholecystokinin Receptors in Gallbladder cancer. A Chandra, J Nigam, M Goel, D Parmar, LK Satyam Journal of Clinical Oncology 37 (15_suppl), e15655-e15655, 2019 | | 2019 |
Research Article Differential Expression of Cholecystokinin A Receptor in Gallbladder Cancer in the Young and Elderly Suggests Two Subsets of the Same Disease? HR Kazmi, A Chandra, K Baghel, A Singh, J Nigam, D Parmar, AA Mahdi, ... | | |